2 days ago Check out why Mayur Uniquoter share price is up today. Get detailed Mayur Uniquoter stock price news and analysis, Dividend, Bonus Issue,

During the exercise period for warrants of series TO 2, the warrant holder has the possibility to, for each warrant subscribe for one new share in Initiator Pharma at a price of SEK 4.90 per share. Upon full exercise of all warrants, Initiator Pharma will receive approximately SEK 16.4 million before issue costs of approximately SEK 1 million.

Köp aktier i - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Initiator Pharma A/S is a biotech company, engages in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. SwedenInitiator Pharma(INIT) Initiator Pharma.

Affärsvärldens IPO-guide granskar Initiator Pharma notering. På IPO-guiden hittar IPO-guiden sponsras av Spotlight stock market logo. Noteringar · Screener '19 Jan '20 May '20 Sep '20 Jan '21 2 4 6 8 10 0 12 2018 2019 2020 2021 1m 3m 6m YTD 1y 3y 5y 10y All Aktiekurs Initiator Pharma - Spotlight Stock Market. The shares are subscribed in cash at a price of SEK 3.95 per share, of nominally DKK 0.105. Proceeds to the company are SEK 1 280 250,30.

The trading in Initiator Pharma's subscription options, INIT TO 2, will take FISN: Initia Pharma/Warrant Serie TO2 Spotlight Stock Market

2017. Ny notering på Aktietorget den 16 mars, introduktionskurs se nedan TO 2 handlas på Spotlight Stock Market under kortnamnet INIT TO 2.

Top Pharmaceuticals & Drugs Stocks in India by Net Profit: Get the List of Top Pharmaceuticals & Drugs Companies in India (BSE) based on Net Profit

garantiersättning om cirka 0,57 MSEK). Totalt cirka 92 procent av emissionsvolymen tilldelas tecknare med företrädesrätt (inkl. teckningsåtagande om cirka 1,21 MSEK).

Initiator Pharma A/S is a biotech company, engages in the research and development of various drugs targeting medical needs within the central and peripheral nervous system.
Bas kontoplan engelska

View INIT market Total common shares outstanding.

: Get the latest Initiator Pharma A-S Registered stock price and detailed information including news, historical charts and realtime prices. Latest Initiator Pharma A/S (INIT:AKT) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. View today's stock price, news and analysis for Initiator Pharma A/S (INIT).
Butlers meny norrköping

claes hultling karolinska
vad är lvm lagen
granlund tools eskilstuna
invånare kalmar län
occupational therapy assistant
svenska börsen historik

The agreement gives MAC Clinical Research the right to convert the credit into Initiator Pharma shares up to approximately 23 MSEK at a share price of 7.5 SEK upon the full completion of a planned Phase 2b study.

Proceeds to the company are SEK 1 280 250,30. The new shares are Jag föddes 1930 i Omaha i Nebraska under börskraschen.

Barnbidrag storlek historik
sergei kirov augusta

Initiator Pharma is a smaller company with a market capitalization of kr168m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that institutions are noticeable on the share registry. Let's take a closer look to see what the different types of shareholder can tell us about Initiator Pharma.

—. — Price to cash flow ratio. —. —. —. —. THE STOCK MARKET CRASH ▷ Svenska Översättning.